Suppr超能文献

2019 年至 2021 年中国四川耐多药或利福平耐药结核分枝杆菌的耐药特征、遗传多样性和传播动态。

Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.

机构信息

Sichuan Center for Disease Control and Prevention, Institute for Tuberculosis Control and Prevention, Chengdu, 610041, Sichuan, China.

出版信息

Antimicrob Resist Infect Control. 2024 Oct 14;13(1):125. doi: 10.1186/s13756-024-01482-6.

Abstract

BACKGROUND

Multidrug- or rifampicin-resistant tuberculosis (TB; MDR/RR-TB) is a significant public health threat. However, the mechanisms involved in its transmission in Sichuan, China are unclear. To provide a scientific basis for MDR/RR-TB control and prevention, we investigated the drug-resistance characteristics, genetic diversity, and transmission dynamics and analyzed the demographic and clinical characteristics of patients to identify risk factors for the acquisition of MDR/RR-TB in Sichuan, Western China.

METHODS

Whole-genome sequencing was performed using a sample comprised of all MDR/RR-TB strains isolated from patients with pulmonary TB (≥ 15 years) at the 22 surveillance sites in Sichuan province between January 2019 and December 2021, to analyze genotypic drug resistance and genetic diversity. Moreover, we performed statistical analyses of the epidemiological characteristics and risk factors associated with the transmission dynamics of MDR/RR-TB.

RESULTS

The final analysis included 278 MDR/RR TB strains. Lineage 2.2, the major sub-lineage, accounted for 82.01% (228/278) of isolates, followed by lineage 4.5 (9.72%, 27/278), lineage 4.4 (6.83%, 19/278), and lineage 4.2 (1.44%, 4/278). The drug resistance rates, ranging from high to low, were as follows: isoniazid (229 [82.37%]), streptomycin (177 [63.67%]), ethambutol (144 [51.80%]), pyrazinamide (PZA, 119 [42.81%]), fluoroquinolones (FQs, 93 [33.45%]). Further, the clofazimine, bedaquiline, and delamanid resistance rates were 2.88, 2.88, and 1.04%, respectively. The gene composition cluster rate was 32.37% (90/278). In addition, 83.81% (233/278) of MDR/RR-TB cases were determined to be likely caused by transmission. Finally, patients infected with lineage two strains and strains with the KatG S315T amino acid substitution presented a higher risk of MDR/RR-TB transmission.

CONCLUSION

Transmission plays a significant role in the MDR/RR-TB burden in Sichuan province, and lineage 2 strains and strains harboring KatG S315T have a high probability of transmission. Further, high levels of FQ and PZA drug resistance suggest an urgent need for drug susceptibility testing prior to designing therapeutic regimens. New anti-TB drugs need to be used standardly and TB strains should be regularly monitored for resistance to these drugs.

摘要

背景

耐多药/利福平耐药结核病(MDR/RR-TB)是一个重大的公共卫生威胁。然而,在中国四川,其传播机制尚不清楚。为了为 MDR/RR-TB 控制和预防提供科学依据,我们调查了药物耐药性特征、遗传多样性以及传播动力学,并分析了患者的人口统计学和临床特征,以确定在中国西部四川省获得 MDR/RR-TB 的危险因素。

方法

对 2019 年 1 月至 2021 年 12 月期间在四川省 22 个监测点从≥15 岁的肺结核(TB)患者中分离的所有 MDR/RR-TB 菌株进行全基因组测序,以分析基因型药物耐药性和遗传多样性。此外,我们对 MDR/RR-TB 传播动力学相关的流行病学特征和危险因素进行了统计分析。

结果

最终分析包括 278 株 MDR/RR-TB 菌株。主要亚谱系 2.2 占分离株的 82.01%(228/278),其次是谱系 4.5(9.72%,27/278)、谱系 4.4(6.83%,19/278)和谱系 4.2(1.44%,4/278)。耐药率从高到低依次为:异烟肼(229[82.37%])、链霉素(177[63.67%])、乙胺丁醇(144[51.80%])、吡嗪酰胺(PZA,119[42.81%])、氟喹诺酮类(FQs,93[33.45%])。进一步,氯法齐明、贝达喹啉和德拉马尼的耐药率分别为 2.88%、2.88%和 1.04%。基因组成簇率为 32.37%(90/278)。此外,83.81%(233/278)的 MDR/RR-TB 病例被确定为可能由传播引起的。最后,感染谱系 2 菌株和携带 KatG S315T 氨基酸取代的菌株的患者,MDR/RR-TB 传播的风险更高。

结论

传播在四川省 MDR/RR-TB 负担中起着重要作用,谱系 2 菌株和携带 KatG S315T 的菌株具有较高的传播可能性。此外,高水平的 FQ 和 PZA 耐药性表明在设计治疗方案之前迫切需要进行药敏试验。需要规范使用新的抗结核药物,并定期监测结核菌株对这些药物的耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8046/11472436/172804c65633/13756_2024_1482_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验